Cargando…

Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells

Detalles Bibliográficos
Autores principales: Di Gesù, Roberto, Bondì, Maria Luisa, Azzolina, Antonina, Craparo, Emanuela Fabiola, Botto, Chiara, Amore, Erika, Giammona, Gaetano, Cervello, Melchiorre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767036/
https://www.ncbi.nlm.nih.gov/pubmed/29331149
http://dx.doi.org/10.1186/s12951-017-0325-y
_version_ 1783292466059804672
author Di Gesù, Roberto
Bondì, Maria Luisa
Azzolina, Antonina
Craparo, Emanuela Fabiola
Botto, Chiara
Amore, Erika
Giammona, Gaetano
Cervello, Melchiorre
author_facet Di Gesù, Roberto
Bondì, Maria Luisa
Azzolina, Antonina
Craparo, Emanuela Fabiola
Botto, Chiara
Amore, Erika
Giammona, Gaetano
Cervello, Melchiorre
author_sort Di Gesù, Roberto
collection PubMed
description
format Online
Article
Text
id pubmed-5767036
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57670362018-01-17 Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells Di Gesù, Roberto Bondì, Maria Luisa Azzolina, Antonina Craparo, Emanuela Fabiola Botto, Chiara Amore, Erika Giammona, Gaetano Cervello, Melchiorre J Nanobiotechnology Correction BioMed Central 2018-01-13 /pmc/articles/PMC5767036/ /pubmed/29331149 http://dx.doi.org/10.1186/s12951-017-0325-y Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Correction
Di Gesù, Roberto
Bondì, Maria Luisa
Azzolina, Antonina
Craparo, Emanuela Fabiola
Botto, Chiara
Amore, Erika
Giammona, Gaetano
Cervello, Melchiorre
Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
title Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
title_full Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
title_fullStr Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
title_full_unstemmed Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
title_short Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
title_sort correction to: entrapment of an egfr inhibitor into nanostructured lipid carriers (nlc) improves its antitumor activity against human hepatocarcinoma cells
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767036/
https://www.ncbi.nlm.nih.gov/pubmed/29331149
http://dx.doi.org/10.1186/s12951-017-0325-y
work_keys_str_mv AT digesuroberto correctiontoentrapmentofanegfrinhibitorintonanostructuredlipidcarriersnlcimprovesitsantitumoractivityagainsthumanhepatocarcinomacells
AT bondimarialuisa correctiontoentrapmentofanegfrinhibitorintonanostructuredlipidcarriersnlcimprovesitsantitumoractivityagainsthumanhepatocarcinomacells
AT azzolinaantonina correctiontoentrapmentofanegfrinhibitorintonanostructuredlipidcarriersnlcimprovesitsantitumoractivityagainsthumanhepatocarcinomacells
AT craparoemanuelafabiola correctiontoentrapmentofanegfrinhibitorintonanostructuredlipidcarriersnlcimprovesitsantitumoractivityagainsthumanhepatocarcinomacells
AT bottochiara correctiontoentrapmentofanegfrinhibitorintonanostructuredlipidcarriersnlcimprovesitsantitumoractivityagainsthumanhepatocarcinomacells
AT amoreerika correctiontoentrapmentofanegfrinhibitorintonanostructuredlipidcarriersnlcimprovesitsantitumoractivityagainsthumanhepatocarcinomacells
AT giammonagaetano correctiontoentrapmentofanegfrinhibitorintonanostructuredlipidcarriersnlcimprovesitsantitumoractivityagainsthumanhepatocarcinomacells
AT cervellomelchiorre correctiontoentrapmentofanegfrinhibitorintonanostructuredlipidcarriersnlcimprovesitsantitumoractivityagainsthumanhepatocarcinomacells